Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.
about
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseEvolving clinical phenotypes in HIV-associated neurocognitive disordersHIV Associated Neurocognitive DisordersThe Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewHIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: role in HIV associated neurocognitive disorderMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesDopamine receptor activation increases HIV entry into primary human macrophagesThe longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders.Functional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults.Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge.Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study.Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease.Gene expression patterns associated with neurological disease in human HIV infectionQuantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphineWorking and episodic memory in HIV infection, alcoholism, and their comorbidity: baseline and 1-year follow-up examinationsIntercellular Adhesion Molecular-5 as Marker in HIV Associated Neurocognitive Disorder.HIV Clade-C Infection and Cognitive Impairment, Fatigue, Depression, and Quality of Life in Early-Stage Infection in Northern Indians.Cross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging.Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.Modeling deficits in attention, inhibition, and flexibility in HAND.Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cellsAntibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study.HIV, dementia and antiretroviral drugs: 30 years of an epidemic.Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brainTreatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-aLaser capture microdissection assessment of virus compartmentalization in the central nervous systems of macaques infected with neurovirulent simian immunodeficiency virusHIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanismUse of Videophone Technology to Address Medication Adherence Issues in Persons with HIV.Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesisControversies in HIV-associated neurocognitive disordersVerbal memory declines more rapidly with age in HIV infected versus uninfected adults
P2860
Q24631745-0EE293EB-DF56-4ADC-B783-F3535B9AE83DQ26770397-DD77E925-863C-400E-B175-21560B9505F8Q26859192-AEB6DF65-F90B-49CA-9D37-7EEA8B84D7F4Q27023968-1508FB27-0B09-4C0D-8C0F-D4212E26B09CQ28066725-0070F45B-1A4D-4367-8765-18A86FEB0312Q28394040-1B9E4BB3-450A-4918-AA42-129915270A2AQ28539889-86204812-6447-4FDF-9695-BAAC2F13673FQ28543414-A0BA1728-C4AE-4162-A255-85C2CDC07369Q30410418-0DD2FB2B-BF49-41BD-9CF4-19998FF73228Q30411844-6A7D81BC-9B03-4A1A-9919-BE202C214F27Q30416710-57FCD851-527A-4694-853D-B9789ECB337CQ30445058-77F97DD0-CF03-4EB9-B942-C808AF2140ACQ30452291-F81EFAF3-F566-49A3-A13E-4E4CFE1D1491Q30513406-4F348EE9-B526-4F88-ABDE-161DB6D15E48Q33265632-C16D13ED-93AB-4AEC-9163-73D5707EF0F8Q33603457-18CA6E7A-BEB8-4458-8259-C285747E15F2Q33605737-F823E587-2EA3-49FA-BA77-0E92E9816599Q33653493-856D0F36-6807-420F-A4B1-BB1110C67D34Q33705847-30841FC0-1219-4F38-99C5-6534D3DD92F8Q33714228-15057583-61E3-4A14-9E31-FFE5C9BC7038Q33737734-C3481E08-E08B-4F27-8BC2-CB8301D97A5DQ33820078-23789843-8886-4619-B0FF-2DD77E633E34Q33842214-009EB4E0-8952-40CF-BD58-BEA64955C83BQ33875335-7BA83EB1-BB10-4770-8F07-8CD59ED8EE85Q33936233-9F1B4DB0-5713-44A3-803F-C8466CC6C35FQ33995872-C8E50C34-174C-4B11-A1E3-48EDEC26AFDAQ34034134-94C8816B-989B-421E-9309-62148E72BF35Q34170914-F98A6A93-50DF-4B07-9C98-1D4BB57E1513Q34387874-F0FB0B1C-5603-4652-9BD4-9C635A842DADQ34573511-8CB8FA6E-8D8C-4F06-BBBA-FFECA1A9677CQ34594600-B8690862-069D-4585-A2F6-835FF4186AD1Q34718135-B4738496-7506-4CD3-B3E4-B74355983234Q34747341-AFA20C8D-19F9-4762-A126-D43CB0F292E7Q34993393-10F50CA9-66BB-4B5B-A2C9-E4DC3945D6BDQ35000860-31C0D6DC-221B-4AC3-8B67-829912232DAEQ35007551-13DE2607-6B2A-4221-A00B-3708D0FCD75FQ35008798-F75ED219-F6B2-4C41-B825-1C462FD298E3Q35032667-E09D8DA8-C01B-4EC8-8FF2-170E37077E5DQ35037015-3F75B310-2325-43AD-8CD9-454E18B9F866Q35050070-AFEC9283-7B0D-444D-A6B1-CFE7693F1DBE
P2860
Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Prevalence and pattern of neur ...... combined study of two cohorts.
@ast
Prevalence and pattern of neur ...... combined study of two cohorts.
@en
Prevalence and pattern of neur ...... ired immunodeficiency syndrome
@nl
type
label
Prevalence and pattern of neur ...... combined study of two cohorts.
@ast
Prevalence and pattern of neur ...... combined study of two cohorts.
@en
Prevalence and pattern of neur ...... ired immunodeficiency syndrome
@nl
prefLabel
Prevalence and pattern of neur ...... combined study of two cohorts.
@ast
Prevalence and pattern of neur ...... combined study of two cohorts.
@en
Prevalence and pattern of neur ...... ired immunodeficiency syndrome
@nl
P921
P1476
Prevalence and pattern of neur ...... combined study of two cohorts
@en
P2093
Bruce J Brew
P2888
P304
P356
10.1080/13550280490521078
P577
2004-12-01T00:00:00Z
P6179
1036423356